{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T13:56:03Z","timestamp":1792418163847,"version":"4.4.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2017,7,21]],"date-time":"2017-07-21T00:00:00Z","timestamp":1500595200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2017,7,21]],"date-time":"2017-07-21T00:00:00Z","timestamp":1500595200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1007\/s00467-017-3720-6","type":"journal-article","created":{"date-parts":[[2017,7,21]],"date-time":"2017-07-21T07:10:32Z","timestamp":1500621032000},"page":"2107-2113","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Evaluation of the safety and efficacy of metoprolol infusion for children and adolescents with hypertensive crises: a retrospective case series"],"prefix":"10.1007","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5064-5638","authenticated-orcid":false,"given":"Rola","family":"Saqan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanan","family":"Thiabat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,21]]},"reference":[{"issue":"4","key":"3720_CR1","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1161\/01.HYP.0000143545.54637.af","volume":"44","author":"B Falkner","year":"2004","unstructured":"Falkner B, Daniels SR (2004) Summary of the fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Hypertension 44(4):387\u2013388","journal-title":"Hypertension"},{"key":"3720_CR2","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2165\/00129784-200303010-00003","volume":"3","author":"M Tuncel","year":"2003","unstructured":"Tuncel M, Ram VC (2003) Hypertensive emergencies. Etiology and management. Am J Cardiovasc Drugs 3:21\u201331","journal-title":"Am J Cardiovasc Drugs"},{"key":"3720_CR3","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1378\/chest.06-2490","volume":"131","author":"PE Marik","year":"2007","unstructured":"Marik PE, Varon J (2007) Hypertensive crises: challenges and management. Chest 131:1949\u20131962","journal-title":"Chest"},{"key":"3720_CR4","doi-asserted-by":"publisher","first-page":"420247","DOI":"10.1155\/2012\/420247","volume":"2012","author":"D Singh","year":"2012","unstructured":"Singh D, Akingbola O, Yosypiv I, El-Dahr S (2012) Emergency management of hypertension in children. Int J Nephrol 2012:420247","journal-title":"Int J Nephrol"},{"key":"3720_CR5","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s11906-014-0425-0","volume":"16","author":"TN Webb","year":"2014","unstructured":"Webb TN, Shatat IF, Miyashita Y (2014) Therapy of acute hypertension in hospitalized children and adolescents. Curr Hypertens Rep 16:425","journal-title":"Curr Hypertens Rep"},{"key":"3720_CR6","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1016\/j.annemergmed.2007.11.010","volume":"51","author":"AM Pancioli","year":"2008","unstructured":"Pancioli AM (2008) Hypertension management in neurologic emergencies. Ann Emerg Med 51:S24\u2013S27","journal-title":"Ann Emerg Med"},{"key":"3720_CR7","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/j.1751-7176.2012.00656.x","volume":"14","author":"WP Welch","year":"2012","unstructured":"Welch WP, Yang W, Taylor-Zapata P, Flynn JT (2012) Antihypertensive drug use by children: are the drugs labeled and indicated? J Clin Hypertens (Greenwich) 14:388\u2013395","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"3720_CR8","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1038\/jhh.2008.25","volume":"22","author":"MI Perez","year":"2008","unstructured":"Perez MI, Musini VM (2008) Pharmacological interventions for hypertensive emergencies: a Cochrane systematic review. J Hum Hypertens 22:596\u2013607","journal-title":"J Hum Hypertens"},{"issue":"4S","key":"3720_CR9","doi-asserted-by":"publisher","first-page":"e130","DOI":"10.1016\/j.jash.2014.03.300","volume":"8","author":"J Flynn","year":"2014","unstructured":"Flynn J, Bradford M, Harvey E (2014) Intravenous hydralazine in hypertensive pediatric inpatients: does it work? Is it safe? J Am Soc Hypertens 8(4S):e130","journal-title":"J Am Soc Hypertens"},{"key":"3720_CR10","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1517\/14740338.2.2.133","volume":"2","author":"JT Flynn","year":"2003","unstructured":"Flynn JT (2003) Safety of short-acting nifedipine in children with severe hypertension. Expert Opin Drug Saf 2:133","journal-title":"Expert Opin Drug Saf"},{"key":"3720_CR11","doi-asserted-by":"publisher","first-page":"F126","DOI":"10.1136\/fn.76.2.F126","volume":"76","author":"JB Gouyon","year":"1997","unstructured":"Gouyon JB, Geneste B, Semama DS, Fran\u00e7oise M, Germain JF (1997) Intravenous nicardipine in hypertensive preterm infants. Arch Dis Child Fetal Neonatal Ed 76:F126\u2013F127","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"3720_CR12","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1067\/mpd.2001.114030","volume":"139","author":"JT Flynn","year":"2001","unstructured":"Flynn JT, Mottes TA, Brophy PD, Kershaw DB, Smoyer WE, Bunchman TE (2001) Intravenous nicardipine for treatment of severe hypertension in children. J Pediatr 139:38\u201343","journal-title":"J Pediatr"},{"key":"3720_CR13","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1097\/PCC.0b013e3181e328d8","volume":"12","author":"CA Thomas","year":"2011","unstructured":"Thomas CA, Moffett BS, Wagner JL, Mott AR, Feig DI (2011) Safety and efficacy of intravenous labetalol for hypertensive crisis in infants and small children. Pediatr Crit Care Med 12:28\u201332","journal-title":"Pediatr Crit Care Med"},{"key":"3720_CR14","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1097\/PCC.0000000000000383","volume":"16","author":"GB Hammer","year":"2015","unstructured":"Hammer GB, Lewandowski A, Drover DR, Rosen DA, Cohane C, Anand R, Mitchell J, Reece T, Schulman SR (2015) Safety and efficacy of sodium nitroprusside during prolonged infusion in pediatric patients. Pediatr Crit Care Med 16:397\u2013403","journal-title":"Pediatr Crit Care Med"},{"key":"3720_CR15","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1345\/aph.1C286","volume":"37","author":"HJ Tangeman","year":"2003","unstructured":"Tangeman HJ, Patterson JH (2003) Extended-release metoprolol succinate in chronic heart failure. Ann Pharmacother 37:701\u2013710","journal-title":"Ann Pharmacother"},{"key":"3720_CR16","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.ahj.2004.05.056","volume":"149","author":"PC Deedwania","year":"2005","unstructured":"Deedwania PC, Giles TD, Klibaner M, Ghali JK, Herlitz J, Hildebrandt P, Kjekshus J, Spinar J, Vitovec J, Stanbrook H, Wikstrand J, MERIT-HF Study Group (2005) Efficacy, safety and tolerability of metoprolol CR\/XL in patients with diabetes and chronic heart failure: experiences from MERIT-HF. Am Heart J 149:159\u2013167","journal-title":"Am Heart J"},{"key":"3720_CR17","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jpeds.2006.09.034","volume":"150","author":"DL Batisky","year":"2007","unstructured":"Batisky DL, Sorof JM, Sugg J, Llewellyn M, Klibaner M, Hainer JW, Portman RJ, Falkner B, Toprol-XL Pediatric Hypertension Investigators (2007) Efficacy and safety of extended release metoprolol succinate in hypertensive children 6 to 16 years of age: a clinical trial experience. J Pediatr 150:134\u2013139 139.e1","journal-title":"J Pediatr"},{"issue":"6","key":"3720_CR18","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","volume":"42","author":"AV Chobanian","year":"2003","unstructured":"Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ, Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee (2003) Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 42(6):1206\u20131252","journal-title":"Hypertension"},{"key":"3720_CR19","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1136\/adc.67.9.1089","volume":"67","author":"JE Deal","year":"1992","unstructured":"Deal JE, Barratt TM, Dillon MJ (1992) Management of hypertensive emergencies. Arch Dis Child 67:1089\u20131092","journal-title":"Arch Dis Child"},{"issue":"2","key":"3720_CR20","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1592\/phco.20.3.140.34782","volume":"20","author":"ME Temple","year":"2000","unstructured":"Temple ME, Nahata MC (2000) Treatment of pediatric hypertension. Pharmacotherapy 20(2):140\u2013150","journal-title":"Pharmacotherapy"},{"key":"3720_CR21","first-page":"49","volume":"9","author":"DR Stein","year":"2016","unstructured":"Stein DR, Ferguson MA (2016) Evaluation and treatment of hypertensive crises in children. Integr Blood Press Control 9:49\u201358","journal-title":"Integr Blood Press Control"},{"key":"3720_CR22","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1007\/s00467-014-2772-0","volume":"29","author":"J Ostrye","year":"2014","unstructured":"Ostrye J, Hailpern SM, Jones J, Egan B, Chessman K, Shatat IF (2014) The efficacy and safety of intravenous hydralazine for the treatment of hypertension in the hospitalized child. Pediatr Nephrol 29:1403\u20131409","journal-title":"Pediatr Nephrol"},{"key":"3720_CR23","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1136\/adc.63.8.975","volume":"63","author":"JH Evans","year":"1988","unstructured":"Evans JH, Shaw NJ, Brocklebank JT (1988) Sublingual nifedipine in acute severe hypertension. Arch Dis Child 63:975\u2013977","journal-title":"Arch Dis Child"},{"key":"3720_CR24","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1067\/mpd.2001.114699","volume":"139","author":"RT Blaszak","year":"2001","unstructured":"Blaszak RT, Savage JA, Ellis EN (2001) The use of short-acting nifedipine in pediatric patients with hypertension. Journal Pediatr 139:34\u201337","journal-title":"Journal Pediatr"},{"key":"3720_CR25","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s004670200006","volume":"17","author":"DW Egger","year":"2002","unstructured":"Egger DW, Deming DD, Hamada N, Perkin RM, Sahney S (2002) Evaluation of the safety of short-acting nifedipine in children with hypertension. Pediatr Nephrol 17:35\u201340","journal-title":"Pediatr Nephrol"},{"key":"3720_CR26","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1136\/pgmj.57.672.633","volume":"57","author":"MJ Ward","year":"1981","unstructured":"Ward MJ, Roland JM, Banks DC (1981) Once-daily metoprolol for hypertension. Postgrad Med J 57:633\u2013634","journal-title":"Postgrad Med J"},{"key":"3720_CR27","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1002\/phar.1319","volume":"33","author":"J Shin","year":"2013","unstructured":"Shin J, Gonzales M, Pletcher MJ (2013) Risk of emergent bradycardia associated with initiation of immediate- or slow-release metoprolol. Pharmacotherapy 33:1353\u20131361","journal-title":"Pharmacotherapy"},{"key":"3720_CR28","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/clpt.1981.81","volume":"29","author":"TA Abraham","year":"1981","unstructured":"Abraham TA, Hasan FM, Fenster PE, Marcus FI (1981) Effect of intravenous metoprolol on reversible obstructive airways disease. Clin Pharmacol Ther 29:582\u2013587","journal-title":"Clin Pharmacol Ther"},{"issue":"Suppl 11","key":"3720_CR29","first-page":"S69","volume":"8","author":"JW Lammers","year":"1986","unstructured":"Lammers JW, Folgering HT, van Herwaarden CL (1986) Respiratory tolerance of bisoprolol and metoprolol in asthmatic patients. J Cardiovasc Pharmacol 8[Suppl 11]:S69\u2013S73","journal-title":"J Cardiovasc Pharmacol"},{"issue":"4","key":"3720_CR30","first-page":"535","volume":"2","author":"K Albouaini","year":"2007","unstructured":"Albouaini K, Andron M, Alahmar A, Egred M (2007) Beta-blockers use in patients with chronic obstructive pulmonary disease and concomitant cardiovascular conditions. Int J Chron Obstruct Pulmon Dis 2(4):535\u2013540","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"3720_CR31","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1097\/PEC.0b013e3181a34816","volume":"25","author":"K Liesemer","year":"2009","unstructured":"Liesemer K, Mullen N (2009) Hypertensive emergency successfully treated with metoprolol: a case report. Pediatr Emerg Care 25:333\u2013335","journal-title":"Pediatr Emerg Care"}],"updated-by":[{"DOI":"10.1007\/s00467-017-3792-3","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2017,9,22]],"date-time":"2017-09-22T00:00:00Z","timestamp":1506038400000}}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-017-3720-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-017-3720-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-017-3720-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T22:06:43Z","timestamp":1744150003000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-017-3720-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,21]]},"references-count":31,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["3720"],"URL":"https:\/\/doi.org\/10.1007\/s00467-017-3720-6","relation":{"erratum":[{"id-type":"doi","id":"10.1007\/s00467-017-3792-3","asserted-by":"object"}]},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,21]]},"assertion":[{"value":"3 January 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2017","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Erratum","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"An erratum to this article has been published.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study formal consent is not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}